<DOC>
	<DOCNO>NCT00398541</DOCNO>
	<brief_summary>Evaluate antihypertensive neuroprotective effect Hyzaar ( R ) elderly subject comparison Natrilix ( TM ) .</brief_summary>
	<brief_title>Evaluation Antihypertensive Effect Hyzaar ( R ) Cognitive Function Hypertensive Patients ( 0954A-322 )</brief_title>
	<detailed_description />
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>ACEi ARB naive take ACEi ARB concurrently least one month runin period Be able carry daily activity Be least 50 year old inclusion study Be diagnose mild moderate hypertension , treat untreated Literate Not take cognitiveenhanced agent baseline Present memory complain ( spontaneous inform caregiver ) Congestive heart failure NYHA class &gt; 2 Renal failure renal insufficiency serum creatinine &gt; 1.4mg/dl chronic severe liver disease abnormal GPT GOT &gt; 2 time upper normal limit Diagnosed major depression enter study Foreign language mother tongue test result reliable History stroke transient ischemic attack ( stroke define focal neurological sign progress stepwise ) Hypersensitive active ingredient component losartan potassium indapamide tablet Major hear loss/deafness and/or major visual impairment/blindness prevent perform test Myocardial infarction within past 6 month Single function kidney Anuria</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>